Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liuliu Huang

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Quantitative Imaging in Medicine and Surgery|May 19, 2025
Evaluation of right ventricular systolic function in patients with rheumatic mitral stenosis by tissue tricuspid annular displacement techniqueMengqian Ou, Yue Li, Wenwen Chi, et al.
Frontiers in Bioengineering and Biotechnology|November 3, 2022
Urokinase-loaded cyclic RGD-decorated liposome targeted therapy for <i>in-situ</i> thrombus of pulmonary arteriole of pulmonary hypertensionJingtao Li, Xiaofeng Zhang, Yingying Mo, et al.
Peerj|August 28, 2024
Study of LY9 as a potential biomarker for prognosis and prediction of immunotherapy efficacy in lung adenocarcinomaKun Deng, Liqiang Yuan, Zhanyu Xu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Quantitative Imaging in Medicine and Surgery|May 19, 2025
Evaluation of right ventricular systolic function in patients with rheumatic mitral stenosis by tissue tricuspid annular displacement techniqueMengqian Ou, Yue Li, Wenwen Chi, et al.
Frontiers in Bioengineering and Biotechnology|November 3, 2022
Urokinase-loaded cyclic RGD-decorated liposome targeted therapy for <i>in-situ</i> thrombus of pulmonary arteriole of pulmonary hypertensionJingtao Li, Xiaofeng Zhang, Yingying Mo, et al.
Peerj|August 28, 2024
Study of LY9 as a potential biomarker for prognosis and prediction of immunotherapy efficacy in lung adenocarcinomaKun Deng, Liqiang Yuan, Zhanyu Xu, et al.
Pageof 2